Multimorbidity
Conditions
Interventions
Group 1: The project consists of a multi-stage process.
Phase 1 (development project): The first step is the development of the digital symptom diary. For this purpose, expert panels and a field rese
Sponsors
Universitätsklinikum HeidelbergAbteilung Allgemeinmedizin und Versorgungsforschung
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Potential participants must be able to agree to participate in a study. In addition, all study participants must declare their informed consent to study participation and data analysation. Special inclusion criteria according to study phases: Feasibility study: Participating patients have to be part of the PraCMan-programme have to have an iOS or Android smartphone/tablet. In Addition their consent to the terms of use of the digital symptom diary is a necessary prerequisite for participation. Participating practices must have actively participated in PraCMan at least 6 months before the start of the TelePraCMan-study. Furthermore, they have to have at least 20 patients within the PraCMan-programme. The use of PraCMan must be covered by a contract with AOK-Baden-Württemberg. The participating practices require at least one GP who is trained in using the PraCMan-software and would like to participate voluntarily in the study, as well as at least one VERAH, who has been trained for PraCMan and is willing to participate actively in the project.
Exclusion criteria
Exclusion criteria: Persons who have no or only very limited skills in speaking German are excluded from study participation. Except in the case of expert panels and field research, persons who suffer from severe visual impairment or other physical or psychological circumstances (e.g. tremor, other serious illness), which hamper the use of a smartphone are also excluded from participation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility study: Effects of the digital symptom diary on the self-management ability of patients (SF-12 questionnaire). The data will be collected individually for each patient at baseline T0 at the beginning of the intervention (start of app use) and as a follow-up at T1 after 6 months of app use. | — |
Secondary
| Measure | Time frame |
|---|---|
| Development project: - Requirements and expectations for TelePraCMan (from the point of view of multimorbid patients, care assistants in the GP's practice and GP's) - Technical affinity (TA-EG questionnaire) - potential acceptance with regard to use in real supply processes - User experience of the digital symptom diary Feasibility study: - Patient self-activation (PAM-13) - Disease-related self-management (SCI-R German, 9-Item European Heart Failure Self-Care Behaviour Scale German, CAF Questionnaire German) - User Experience and Feasibility (User Experience Questionnaire) The data will be collected individually for each patient at baseline T0 at the beginning of the intervention (start of app use) and as a follow-up at T1 after 6 months of app use. | — |
Countries
Germany
Contacts
Public ContactLars Wiezorreck
Abteilung Allgemeinmedizin und Versorgungsforschung
Outcome results
None listed